Status:

UNKNOWN

Ultrasonographic Evaluation of Diaphragm and Quadriceps in Chronic Obstructive Pulmonary Disease (COPD) Patients

Lead Sponsor:

IRCCS San Raffaele Roma

Conditions:

COPD

COPD Exacerbation

Eligibility:

All Genders

60+ years

Brief Summary

The purpose of this study is to evaluate the prognostic role of echographic diaphragmatic assessment and vastus lateralis muscle ultrasound (US) in two independent populations of patients hospitalized...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Group A):
  • COPD diagnosis
  • previous or actual cigarette smoking history
  • COPD exacerbation requiring hospitalization
  • Obtained written informed consent
  • Exclusion Criteria:
  • Pleural effusion extended for more than two intercostal spaces
  • Interstitial lung diseases
  • Major surgery in the previous 30 days
  • Right pleurodesis or fibrothorax
  • Right stroke outcomes
  • Technical impossibility to perform ultrasound evaluations
  • conditions, clinical or otherwise, that in the investigator's judgment may interfere with the study, or not recommending participation for security reasons
  • Absence of written informed consent
  • Inclusion Criteria (Group B):
  • COPD diagnosis
  • previous or actual cigarette smoking history
  • COPD exacerbation requiring hospitalization in the previous 30 days
  • Indication to undergo a pulmonary rehabilitation protocol
  • Obtained written informed consent
  • Exclusion Criteria:
  • Pleural effusion extended for more than two intercostal spaces
  • Interstitial lung diseases
  • Major surgery in the previous 30 days
  • Right pleurodesis or fibrothorax
  • Right stroke outcomes
  • Technical impossibility to perform ultrasound evaluations
  • conditions, clinical or otherwise, that in the investigator's judgment may interfere with the study, or not recommending participation for security reasons
  • Absence of written informed consent

Exclusion

    Key Trial Info

    Start Date :

    December 1 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 1 2024

    Estimated Enrollment :

    200 Patients enrolled

    Trial Details

    Trial ID

    NCT04509128

    Start Date

    December 1 2023

    End Date

    April 1 2024

    Last Update

    June 22 2023

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.